High dose, long-term daily interferon plus ribavirin combination therapy for HCV (genotype 1 and non genotype 1)non responders.

被引:0
|
作者
Lurie, Y
Beer-Gabel, M
Malnick, SDH
Keter, D
Rimon, E
Mosenkis, B
Stalgis, C
Brass, DD
机构
[1] Kaplan Hosp, Tel Aviv, Israel
[2] Schering Plough, Bloomfield, NJ USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1837
引用
收藏
页码:620A / 620A
页数:1
相关论文
共 50 条
  • [1] Combination of interferon induction therapy and ribavirin in primary interferon non-responders infected with genotype 1 hepatitis C virus
    Erdem, L
    Akbayir, N
    Cakaloglu, Y
    Cevikbas, U
    Badur, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 234 - 234
  • [2] Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders
    Jensen, Donald
    Sherman, Kenneth E.
    Hezode, Christophe
    Pol, Stanislas
    Zeuzem, Stefan
    de Ledinghen, Victor
    Tran, Albert
    Elkhashab, Magdy
    Younes, Ziad H.
    Kugelmas, Marcelo
    Mauss, Stefan
    Everson, Gregory
    Luketic, Velimir
    Vierling, John
    Serfaty, Lawrence
    Brunetto, Maurizia
    Heo, Jeong
    Bernstein, David
    McPhee, Fiona
    Hennicken, Delphine
    Mendez, Patricia
    Hughes, Eric
    Noviello, Stephanie
    JOURNAL OF HEPATOLOGY, 2015, 63 (01) : 30 - 37
  • [3] Daily therapy for 12 weeks with IFN α 2b plus Ribavirin in non-responders with HCV-RNA genotype 1.
    Lurie, Y
    Esteban-Mur, R
    Buti, M
    Esteban-Mur, JI
    Stalgis, C
    HEPATOLOGY, 1998, 28 (04) : 285A - 285A
  • [4] Response to high ribavirin dose in combination with peg-INF alfa-2a for treatment of HCV genotype 1 previous non-responders
    Hornfeldt, Erika
    Stahle, Lars
    Schvarcz, Robert
    Weiland, Ola R.
    Carlsson, Tony
    Hollander, Anna
    Lindahl, Karin
    HEPATOLOGY, 2007, 46 (04) : 350A - 350A
  • [5] Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1
    Akuta, Norio
    Suzuki, Fumitaka
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (07) : 1097 - 1105
  • [6] Early Virological Response with Consensus Interferon and Ribavirin in HCV Genotype 3 Non-Responders and Relapsers to Pegylated Interferon Based Therapy
    Shakir, Tanzila
    Abbas, Zaigham
    Memon, Sadik
    Tayyab, Ghias
    Shaikh, Kashif
    Nasir, Bilal
    Hassan, Ghias
    Subhan, Amna
    Hamid, Saeed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S122 - S123
  • [7] High and daily dosing therapy with consensus interferon plus ribavirin for combination therapy non-responders with chronic hepatitis C.
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    HEPATOLOGY, 2001, 34 (04) : 582A - 582A
  • [8] Combination of interferon alpha and ribavirin in chronic hepatitis C non responders to interferon monotherapy: Role of genotype and age
    Fargion, S
    Bruno, S
    Borzio, M
    Bissoli, F
    Zuin, M
    Orlandi, A
    Battezzati, P
    Maraschi, A
    Chiesa, A
    Fiorelli, G
    Podda, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 205 - 205
  • [9] High dose induction interferon therapy followed by combination therapy with ribavirin for hepatitis C non-responders.
    Kaiser, S
    Kreysel, C
    Zeitz, M
    Schneider, W
    Domschke, W
    Menzel, M
    Gregor, M
    GASTROENTEROLOGY, 2000, 118 (04) : A950 - A950
  • [10] EFFICACY AND SAFETY OF AN INTENSIFIED REGIMEN OF PEGYLATED INTERFERON ALFA-2A PLUS RIBAVIRIN IN HCV GENOTYPE 1 NON-RESPONDERS: AN INTERIM ANALYSIS OF THE SYREN TRIAL
    Hezode, C.
    Foucher, J.
    Bronowicki, J. -P.
    Leroy, V.
    Tran, A.
    Larrey, D.
    Mathurin, P.
    Rosa, I.
    Alric, L.
    Dhalluin-Venier, V.
    Nani, A.
    Bouvier-Alias, M.
    Rouanet, S.
    Couzigou, P.
    Mallat, A.
    Charaf-Eddine, M.
    Pawlotsky, J. -M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S50 - S50